Search results
First epinephrine nasal spray clears key FDA hurdle
CBS News via Yahoo News· 1 year agoA committee of the Food and Drug Administration's outside advisers voted Thursday in favor of an epinephrine nasal spray product, clearing a key hurdle...
FDA declines to approve needle-free epinephrine, asks drugmaker for more data
CNN via Yahoo News· 8 months agoThe US Food and Drug Administration on Tuesday did not approve a needle-free epinephrine for...
Children help Nasa prove ‘life-saving’ EpiPen injections can become ‘extremely poisonous’ in space
The Independent UK via AOL· 1 year agoSchool students in Canada teaming up with Nasa have found that an injection used to treat severe...
An EpiPen Alternative Could Make Treating Anaphylaxis Easier—Especially in Schools
Verywell Health via Yahoo News· 8 months agoA nasal epinephrine spray, called neffy, has been produced by ARS Pharma as an alternative to the...
ARS Pharma (SPRY) Gets FDA Panel Vote for Epinephrine Nasal Spray
Zacks via Yahoo Finance· 1 year agoARS Pharmaceuticals’ SPRY shares rallied almost 78% on Friday. The significant increase was due to a...
ARS Pharmaceuticals (SPRY) Down on CRL for Nasal Spray
Zacks via Yahoo Finance· 8 months agoShares of ARS Pharmaceuticals, Inc. SPRY plummeted 55.8% on Sep 20 after the company received a...
FDA declines approval bid for Neffy, a needle-free EpiPen alternative
CBS News via Yahoo News· 9 months agoASR Pharma said it was surprised and "deeply disappointed" by the FDA request for more trial data on...
Aquestive Therapeutics Reveals Favorable Data From Epinephrine Trial For Allergies
Benzinga via Yahoo Finance· 2 years agoAquestive Therapeutics Inc (NASDAQ: AQST) announced topline results from the first three arms of...
Why the FDA Rejected This EpiPen-Alternative Nasal Spray
SheKnows via Yahoo News· 8 months agoNeffy, an epinephrine nasal spray designed to decrease severe allergic reactions and serve as an...
Aquestive's AQST-109 Compares Favorably To Widely Used EpiPen For Severe Allergic Reaction
Benzinga via Yahoo Finance· 2 years agoAquestive Therapeutics Inc (NASDAQ: AQST) announced positive topline results from the EPIPHAST 2...